☰

Erin N. Howe, Ph.D. - Publications

Affiliations: 
2012 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Oncology, Cell Biology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Palakurthi B, Fross SR, Guldner IH, Aleksandrovic E, Liu X, Martino AK, Wang Q, Neff RA, Golomb SM, Lewis C, Peng Y, Howe EN, Zhang S. Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer. Nature Communications. 14: 2109. PMID 37055410 DOI: 10.1038/s41467-023-37727-y  0.699
2021 Bahcecioglu G, Yue X, Howe E, Guldner I, Stack MS, Nakshatri H, Zhang S, Zorlutuna P. Aged Breast Extracellular Matrix Drives Mammary Epithelial Cells to an Invasive and Cancer-Like Phenotype. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2100128. PMID 34617419 DOI: 10.1002/advs.202100128  0.802
2020 Guldner IH, Wang Q, Yang L, Golomb SM, Zhao Z, Lopez JA, Brunory A, Howe EN, Zhang Y, Palakurthi B, Barron M, Gao H, Xuei X, Liu Y, Li J, et al. CNS-Native Myeloid Cells Drive Immune Suppression in the Brain Metastatic Niche through Cxcl10. Cell. PMID 33113353 DOI: 10.1016/j.cell.2020.09.064  0.738
2020 Howe EN, Burnette MD, Justice ME, Schnepp PM, Hedrick V, Clancy JW, Guldner IH, Lamere AT, Li J, Aryal UK, D'Souza-Schorey C, Zartman JJ, Zhang S. Rab11b-mediated integrin recycling promotes brain metastatic adaptation and outgrowth. Nature Communications. 11: 3017. PMID 32541798 DOI: 10.1038/S41467-020-16832-2  0.776
2019 Ni Y, Schmidt KR, Werner BA, Koenig JK, Guldner IH, Schnepp PM, Tan X, Jiang L, Host M, Sun L, Howe EN, Wu J, Littlepage LE, Nakshatri H, Zhang S. Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer. Nature Communications. 10: 2860. PMID 31253784 DOI: 10.1038/S41467-019-10743-7  0.774
2019 Rodriguez K, Howe E, Bacher E, Burnette M, Meloche J, Meisel J, Schnepp P, Tan X, Chang M, Zartman J, Zhang S, Ashfeld BL. Combined Scaffold Evaluation and Systems-level Transcriptome-Based Analysis for Accelerated Lead Optimization Reveals Ribosomal Targeting Spirooxindole Cyclopropanes. Chemmedchem. PMID 31140738 DOI: 10.1002/Cmdc.201900266  0.76
2019 Rodriguez KX, Howe EN, Bacher EP, Burnette M, Meloche JL, Meisel J, Schnepp P, Tan X, Chang M, Zartman J, Zhang S, Ashfeld BL. Front Cover: Combined Scaffold Evaluation and Systems‐Level Transcriptome‐Based Analysis for Accelerated Lead Optimization Reveals Ribosomal Targeting Spirooxindole Cyclopropanes (ChemMedChem 18/2019) Chemmedchem. 14: 1618-1618. DOI: 10.1002/Cmdc.201900502  0.723
2018 O'Tighearnaigh TK, Howe EN, Schnepp PM, Zhang S. Abstract LB-359: Role of metabolic adaptation to the brain microenvironment in facilitating brain metastasis progression Tumor Biology. DOI: 10.1158/1538-7445.Am2018-Lb-359  0.773
2017 Schnepp PM, Lee DD, Guldner IH, O'Tighearnaigh TK, Howe EN, Palakurthi B, Eckert KE, Toni TA, Ashfeld BL, Zhang S. GAD1 Upregulation Programs Aggressive Features of Cancer Cell Metabolism in the Brain Metastatic Microenvironment. Cancer Research. PMID 28400476 DOI: 10.1158/0008-5472.Can-16-2289  0.753
2017 Zellmer VR, Schnepp PM, Fracci SL, Tan X, Howe EN, Zhang S. Tumor-induced Stromal STAT1 Accelerates Breast Cancer via Deregulating Tissue Homeostasis. Molecular Cancer Research : McR. PMID 28108623 DOI: 10.1158/1541-7786.Mcr-16-0312  0.79
2017 Zellmer VR, Schnepp PM, Fracci SL, Tan X, Howe EN, Zhang S. Abstract 2983: Tumor induced stromal STAT1 deregulates mammary tissue homeostasis and accelerates breast cancer Cancer Research. 77: 2983-2983. DOI: 10.1158/1538-7445.Am2017-2983  0.777
2014 Wahdan-Alaswad RS, Cochrane DR, Spoelstra NS, Howe EN, Edgerton SM, Anderson SM, Thor AD, Richer JK. Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b. Hormones & Cancer. 5: 374-89. PMID 25213330 DOI: 10.1007/S12672-014-0188-8  0.687
2014 Cochrane DR, Bernales S, Jacobsen BM, Cittelly DM, Howe EN, D'Amato NC, Spoelstra NS, Edgerton SM, Jean A, Guerrero J, Gómez F, Medicherla S, Alfaro IE, McCullagh E, Jedlicka P, et al. Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide. Breast Cancer Research : Bcr. 16: R7. PMID 24451109 DOI: 10.1186/Bcr3599  0.674
2014 Howe EN, Brown RM, Szmulewitz RZ, Rinker-Schaeffer CW. Abstract 4962: Derivation of bone trophic human prostate cancer cells Cancer Research. 74: 4962-4962. DOI: 10.1158/1538-7445.Am2014-4962  0.37
2013 D'Amato NC, Howe EN, Richer JK. MicroRNA regulation of epithelial plasticity in cancer Cancer Letters. 341: 46-55. PMID 23228634 DOI: 10.1016/J.Canlet.2012.11.054  0.592
2013 Cittelly DM, Finlay-Schultz J, Howe EN, Spoelstra NS, Axlund SD, Hendricks P, Jacobsen BM, Sartorius CA, Richer JK. Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4 Oncogene. 32: 2555-2564. PMID 22751119 DOI: 10.1038/Onc.2012.275  0.696
2013 Howe EN, Krishnan V, Otto K, Szmulewitz RZ, Rinker-Schaeffer C. Abstract B95: Examining reciprocal temporal interactions between human prostate cancer cells and the bone microenvironment Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-B95  0.403
2013 Cittelly DM, Cochrane DR, Howe EN, Dimitrova I, Post MD, Russell BR, Spillman MA, Richer JK. Abstract B70: Decreasing ovarian cancer metastases and progression via restoration of microRNAs that target mediators of anoikis- and chemoresistance. Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-B70  0.664
2012 Howe EN, Cochrane DR, Cittelly DM, Richer JK. miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer Plos One. 7. PMID 23185507 DOI: 10.1371/Journal.Pone.0049987  0.704
2012 Cittelly DM, Dimitrova I, Howe EN, Cochrane DR, Jean A, Spoelstra NS, Post MD, Lu X, Broaddus RR, Spillman MA, Richer JK. Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel. Molecular Cancer Therapeutics. 11: 2556-65. PMID 23074172 DOI: 10.1158/1535-7163.Mct-12-0463  0.642
2012 Howe EN, Cochrane DR, Richer JK. The miR-200 and miR-221/222 microRNA families: Opposing effects on epithelial identity Journal of Mammary Gland Biology and Neoplasia. 17: 65-77. PMID 22350980 DOI: 10.1007/S10911-012-9244-6  0.668
2012 Cochrane DR, Jacobsen BM, Connaghan KD, Howe EN, Bain DL, Richer JK. Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer Molecular and Cellular Endocrinology. 355: 15-24. PMID 22330642 DOI: 10.1016/J.Mce.2011.12.020  0.637
2012 Elias AD, Cochrane DR, Jacobsen BM, Cittelly DM, Howe EN, Jean A, Spoelstra NS, Protter AA, Richer JK. Effect of MDV3100, an androgen receptor signaling inhibitor, on tumor growth of estrogen and androgen receptor-positive (ER+/AR+) breast cancer xenografts. Journal of Clinical Oncology. 30: 564-564. DOI: 10.1200/Jco.2012.30.15_Suppl.564  0.691
2012 Cochrane DR, Jacobsen BM, Cittelly DM, Howe EN, Jean A, Spoelstra NS, Bernales S, Protter AA, Elias AD, Richer JK. Abstract LB-109: MDV3100, an androgen receptor signaling inhibitor, inhibits tumor growth in breast cancer preclinical models regardless of estrogen receptor status Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-109  0.69
2011 Howe EN, Cochrane DR, Richer JK. Targets of miR-200c mediate suppression of cell motility and anoikis resistance Breast Cancer Research. 13. PMID 21501518 DOI: 10.1186/Bcr2867  0.615
2011 Richer JK, Howe EN, Cochrane DR. Abstract 137: MicroRNA-200c restores anoikis sensitivity in breast and gynecological cancers Cancer Research. 71: 137-137. DOI: 10.1158/1538-7445.Am2011-137  0.628
2010 Cochrane DR, Cittelly DM, Howe EN, Spoelstra NS, McKinsey EL, LaPara K, Elias A, Yee D, Richer JK. MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer Hormones and Cancer. 1: 306-319. PMID 21761362 DOI: 10.1007/S12672-010-0043-5  0.631
2010 Cochrane DR, Howe EN, Spoelstra NS, Richer JK. Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. Journal of Oncology. 2010: 821717. PMID 20049172 DOI: 10.1155/2010/821717  0.607
2009 Cochrane DR, Spoelstra NS, Howe EN, Nordeen SK, Richer JK. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents Molecular Cancer Therapeutics. 8: 1055-1066. PMID 19435871 DOI: 10.1158/1535-7163.Mct-08-1046  0.623
2008 Singh M, Spoelstra NS, Jean A, Howe E, Torkko KC, Clark HR, Darling DS, Shroyer KR, Horwitz KB, Broaddus RR, Richer JK. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 21: 912-23. PMID 18487993 DOI: 10.1038/Modpathol.2008.82  0.673
Show low-probability matches.